Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5863 posts found.

astrazeneca_building_white

AstraZeneca scores accelerated approval in US and Europe for respiratory syncytial virus drug

February 5, 2019 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, EMA, FDA, MEDI8897, pharma, respiratory syncytial virus

It’s a double victory for AstraZeneca as the company announced its F monoclonal antibody MEDI8897 has been granted accelerated review …
News

More than 200 Xanax-related deaths in UK since 2015

February 5, 2019 Manufacturing and Production Pfizer, UK, benzodiazepines, health, public health, xanax

There have been more than 200 deaths linked to misuse of the anti-anxiety drug Xanax in the UK since 2015. …
News
opioid_pills

Reformulated OxyContin led to spike in Hepatitis C infections

February 5, 2019 Manufacturing and Production OxyContin, USA, hepatitis C, heroin, infectious diseases, opioids

Efforts to create an “abuse deterrent” OxyContin pill inadvertently led to an increase in the number of Hepatitis C infections, …
News
bernie_in_phoenix_2015_2

Sanders calls on Catalyst pharma to justify $375,000 price tag for rare disease drug which was once free

February 5, 2019 Manufacturing and Production Catalyst Pharmaceuticals, Jacobus Pharmaceuticals, Sanders, USA, pharma, pricing

Shares in Catalyst Pharmaceuticals plummeted Monday, after US Senator Bernie Sanders sent the firm a letter asking them to justify …
News
alexander_hardy

Alexander Hardy returns to Genentech as new CEO

February 4, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, appointment, pharma

Genetech, the biotech subsidiary of Swiss firm Roche, has named its new CEO, revealing that Alexander Hardy will be returning …
Appointment
falsified_medicines

Counterfeit drugs – countering the lies

February 4, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Counterfeit drugs, IP, counterfeit medicines, falsified medicines, intellectual property, law, legal, patent

As the Falsified Medicines Directive comes into effect in February 2019, Louis Goss fact checks ‘common sense’ claims on counterfeit …
Feature
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

February 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, England, NHS, Purdue, Vertex, insys, israel, oncology, pharma, top 10

Scandal dominated this week’s news after Sunrise Lee, a stripper turned Insys sales rep was alleged to have given a …
News
both_together

Repurposed drugs: The Supreme Court deals a blow to patentees

January 31, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Supreme Court, drug repurposing, feature, patents, pharma

Second medical use patents protect the discovery that an existing drug is effective to treat a new condition. But, following …
Feature
richard_ridinger

Richard Ridinger resigns from CEO position at Lonza causing shares to plummet

January 30, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Lonza, Marc Funk, Richard Ridinger, Switzerland

Richard Ridinger, the CEO of Swiss biotechnology firm Lonza Group, will step down from his position in March of this …
Appointment
pharmafocus_janfeb_2019_cover

Read Pharmafocus January/February 2019 edition online now!

January 30, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, Counterfeit drugs, NHS, Pharmafocus, WHO, brexit, pharma, vaccines

We’re slowly edging towards warmer months, but the New Year brings more than just the promise of more amicable weather; …
News
920x920

Opioid drugmaker Purdue Pharma inks deal with Alivio over non-opioid inflammation drug

January 29, 2019 Manufacturing and Production Alivio, Purdue Pharma, health, inflammation, opioids

Opioid drugmaker Purdue Pharma has entered into an agreement with inflammatory disease specialist Alivio Therapeutics for the development of the …
News

Imbruvica combo scores expanded FDA approval in most common adult form of leukaemia

January 29, 2019 Manufacturing and Production, Sales and Marketing AbbVie, Cancer, Janssen, imbruvica, leukaemia, pharma

It’s big news for Janssen and AbbVie as it emerged that their jointly-developed Bruton’s tyrosine kinase (BTK) inhibitor Imbruvica (ibrutinib) …
News
800px-t_lymphocyte_16760076824

Precision cancer treatment for dogs moves towards human testing

January 29, 2019 Manufacturing and Production CAR-T therapy, Cancer, Precision Medicine, car t therapy, dogs, t cells, t-cells

Scientists at the University of Missouri have developed a patient specific, precision medicine treatment for bone cancer in dogs. The …
News
shutterstock_168864905

Destiny Pharma secures £1.6m grant to fight ‘superbugs’ and antimicrobial resistance

January 29, 2019 Manufacturing and Production, Research and Development Destiny Pharma, antimicrobial resistance, pharma

UK biotech Destiny Pharma has secured £1.6 million in funding to further its research into the prevention and elimination of …
News
1280px-old_surgical_hospital_drummond_street

Edinburgh researchers genetically modify chickens to produce medicine filled eggs

January 29, 2019 Manufacturing and Production Edinburgh, cancer drugs, medicines, monoclonal antibodies, proteins

Researchers at the University of Edinburgh have genetically modified chickens, meaning that they lay eggs containing human proteins which can …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026